Aldebaran Financial’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.16M Buy
4,728
+1
+0% +$233 1.1% 23
2025
Q4
$978K Sell
4,727
-425
-8% -$84K 0.91% 27
2025
Q3
$955K Sell
5,152
-519
-9% -$88.9K 0.96% 24
2025
Q2
$866K Sell
5,671
-224
-4% -$34.4K 0.96% 24
2025
Q1
$978K Sell
5,895
-886
-13% -$139K 1.19% 22
2024
Q4
$972K Sell
6,781
-406
-6% -$62.9K 1.14% 22
2024
Q3
$1.16M Sell
7,187
-1,354
-16% -$216K 1.37% 18
2024
Q2
$1.25M Sell
8,541
-556
-6% -$82.7K 1.64% 18
2024
Q1
$1.44M Sell
9,097
-895
-9% -$142K 2.03% 15
2023
Q4
$1.57M Sell
9,992
-186
-2% -$28.5K 2.31% 12
2023
Q3
$1.59M Sell
10,178
-800
-7% -$132K 2.47% 11
2023
Q2
$1.82M Sell
10,978
-1,155
-10% -$186K 2.47% 11
2023
Q1
$1.88M Sell
12,133
-3,927
-24% -$634K 2.43% 11
2022
Q4
$2.84M Sell
16,060
-297
-2% -$51.3K 3.05% 8
2022
Q3
$2.66M Sell
16,357
-20
-0.1% -$3.38K 2.93% 6
2022
Q2
$2.91M Sell
16,377
-1,405
-8% -$250K 3.08% 6
2022
Q1
$3.15M Buy
17,782
+308
+2% +$52.4K 2.45% 8
2021
Q4
$2.99M Sell
17,474
-122
-0.7% -$20K 2.21% 10
2021
Q3
$2.84M Sell
17,596
-27
-0.2% -$4.61K 2.3% 10
2021
Q2
$2.92M Sell
17,623
-382
-2% -$63.2K 2.4% 9
2021
Q1
$2.96M Sell
18,005
-376
-2% -$60.8K 2.61% 8
2020
Q4
$2.89M Sell
18,381
-1,553
-8% -$229K 2.69% 8
2020
Q3
$2.97M Buy
19,934
+734
+4% +$109K 3.09% 7
2020
Q2
$2.7M Sell
19,200
-2,173
-10% -$317K 3.17% 6
2020
Q1
$2.8M Sell
21,373
-324
-1% -$46K 2.74% 7
2019
Q4
$3.17M Sell
21,697
-6,179
-22% -$838K 2.4% 11
2019
Q3
$3.62M Sell
27,876
-148
-0.5% -$19.5K 2.42% 10
2019
Q2
$3.9M Sell
28,024
-213
-0.8% -$29.5K 2.7% 8
2019
Q1
$3.95M Sell
28,237
-4,484
-14% -$601K 2.78% 6
2018
Q4
$4.22M Sell
32,721
-1,073
-3% -$150K 3.21% 4
2018
Q3
$4.67M Sell
33,794
-639
-2% -$84.9K 3.03% 6
2018
Q2
$4.18M Sell
34,433
-2,883
-8% -$360K 2.87% 6
2018
Q1
$4.78M Buy
37,316
+543
+1% +$73.4K 3.21% 2
2017
Q4
$5.14M Buy
36,773
+132
+0.4% +$18.4K 3.41% 1
2017
Q3
$4.76M Buy
36,641
+48
+0.1% +$6.36K 3.29% 3
2017
Q2
$4.84M Buy
36,593
+7,999
+28% +$1.02M 3.53% 3
2017
Q1
$3.56M Buy
28,594
+51
+0.2% +$6.09K 2.71% 9
2016
Q4
$3.29M Buy
28,543
+1,823
+7% +$211K 2.6% 7
2016
Q3
$3.16M Sell
26,720
-363
-1% -$44K 2.5% 7
2016
Q2
$3.33M Sell
27,083
-256
-0.9% -$29.1K 2.67% 6
2016
Q1
$2.96M Buy
27,339
+313
+1% +$32.4K 2.58% 8
2015
Q4
$2.72M Buy
27,026
+249
+0.9% +$25K 2.52% 8
2015
Q3
$2.5M Buy
26,777
+509
+2% +$49.2K 2.37% 10
2015
Q2
$2.56M Buy
26,268
+614
+2% +$61.5K 2.16% 14
2015
Q1
$2.58M Buy
25,654
+663
+3% +$67.4K 2.21% 11
2014
Q4
$2.61M Sell
24,991
-1,289
-5% -$136K 2.3% 8
2014
Q3
$2.8M Sell
26,280
-2,463
-9% -$255K 2.5% 7
2014
Q2
$3.01M Sell
28,743
-213
-0.7% -$21.5K 2.37% 6
2014
Q1
$2.84M Buy
28,956
+2,887
+11% +$268K 2.48% 5
2013
Q4
$2.37M Buy
+26,069
New +$2.4M 2.26% 8

Other funds holding JNJ

Aldebaran Financial's JNJ Position: Q1 2026 in Review

Aldebaran Financial increased its Johnson & Johnson (JNJ) stake by 0.02% in Q1 2026, buying an estimated $233 and bringing the position to 4,728 shares worth $1.16M. The position accounts for 1.1% of the portfolio, ranked #23.

Aldebaran Financial first reported a position in JNJ in Q4 2013 and has held it in 50 quarters since. The position peaked at $5.14M in Q4 2017. 4,613 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Aldebaran Financial held 4,728 shares of Johnson & Johnson worth $1.16M as of Q1 2026.
  • Aldebaran Financial bought 1 Johnson & Johnson share in Q1 2026, an estimated $233.
  • Johnson & Johnson made up 1.1% of Aldebaran Financial's portfolio in Q1 2026, its #23 holding.
  • Aldebaran Financial first reported a position in Johnson & Johnson in Q4 2013 and has held it in 50 quarters since.
  • Aldebaran Financial's Johnson & Johnson position peaked at $5.14M in Q4 2017.
  • 4,613 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Aldebaran Financial's 13F filing for Q1 2026, filed 14 May 2026.